Etonitazene 5-cyano analogue

From WikiMD's WELLNESSPEDIA

Etonitazene 5-cyano analogue is a potent opioid analogue of etonitazene, which is itself an opioid approximately 1000-1500 times more potent than morphine. The 5-cyano analogue is a modification of the etonitazene molecule, with a cyano group added at the 5 position. This modification results in a compound that is significantly more potent than the parent compound.

Chemistry[edit]

Etonitazene 5-cyano analogue belongs to the benzimidazole class of opioids. It is structurally related to other benzimidazole opioids such as clonitazene and nitazene. The addition of a cyano group at the 5 position of the molecule increases the potency of the compound, although the exact mechanism of this increase is not fully understood.

Pharmacology[edit]

Like other opioids, etonitazene 5-cyano analogue acts on the mu-opioid receptor in the brain and spinal cord, producing analgesia and sedation. It is thought to be one of the most potent opioids ever synthesized, although its exact potency relative to other opioids is not known.

Legal status[edit]

Etonitazene 5-cyano analogue is a controlled substance in many countries due to its high potency and potential for abuse. In the United States, it is classified as a Schedule I drug under the Controlled Substances Act.

See also[edit]

References[edit]


This article is a stub related to pharmacology. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.